What is Strategic Partners A/S (OZYMF) stock price today?

Strategic Partners A/S (OZYMF) is currently trading at $90.00, up 0% today.

What is OZYMF P/E ratio?

Strategic Partners A/S's P/E ratio is -36.17. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is OZYMF return on equity (ROE)?

Strategic Partners A/S's return on equity (ROE) is -4.71%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Strategic Partners A/S's market cap?

Strategic Partners A/S has a market capitalization of $3.72M.

OTC · Biotechnology

Strategic Partners A/S (OZYMF) Stock

$90.00 +0.00% OTC: OZYMF Healthcare

Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev.

Valuation

Metric	Value
Price	$90.00
Market Cap	$3.72M
P/E Ratio	-36.17
P/B Ratio	1.69
P/S Ratio	99.69
EPS (TTM)	$-21.00
52-Week High	$90.00
52-Week Low	$0.09
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	-4.71%
ROA	-4.40%
ROCE	-13.30%
Gross Margin	100.00%
Operating Margin	-791.59%
Net Margin	-277.99%
Debt/Equity	0.00
Current Ratio	13.90

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$36.0M	$0	$0	$0	$0
Operating Profit	$-83.0M	$-41.0M	$-27.0M	$0	$-2.0M
Net Profit	$-627.0M	$-111.0M	$-26.0M	$0	$-1.0M
EPS	$-2247.53	$-3.14	$0.00	$-8.00	$-21.00
Op Margin	-230.6%	—	—	—	-791.6%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$173.0M	$57.0M	$19.0M	$24.0M	$20.0M
Total Liabilities	$164.0M	$16.0M	$5.0M	$4.0M	$1.0M
Cash	$102.0M	$39.0M	$11.0M	$4.0M	$0
Borrowings	$40.0M	$0	$0	$0	$0

Latest News

Blackstone's Record Fundraising Cycle to Boost Management Fee Growth, RBC Says MT Newswires · Jul 24, 2026 Blackstone vehicle suggests even liquidity providers need liquidity solutions Pitchbook · Jun 8, 2026 Blackstone Eyes $2B Fund Stake Sale GuruFocus.com · Jun 8, 2026 Blackstone Looks to Offload $2 Billion in Private Fund Stakes GuruFocus.com · Jun 8, 2026 Ideal Power announces $30M raise to advance B-TRAN semiconductor commercialization Proactive · May 15, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-603.0M	$0	$0	$-3.0M	$-2.0M
Investing Cash Flow	$-1.0M	$0	$-7.0M	$-9.0M	$-1.0M
Financing Cash Flow	$-2.0M	$0	$-3.0M	$0	$0
Net Cash Flow	$-625.0M	$0	$-28.0M	$-7.0M	$-3.0M
Free Cash Flow	$-604.0M	$0	$0	$-3.0M	$-2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-53.74%
Quick Ratio	13.90
Interest Coverage	—
Return 1Y	—
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held56.74%

Institutions Held5.86%

Institutions Float Held13.55%

Institutional Holder	Shares	Report Date
SPDR Portfolio Developed World ex-US ETF	51,297	2022-08-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
EVLOEvelo Biosciences, Inc.	$0.00	—	0.00	$1898	0.00%
HLUNHEALTHeUNIVERSE, Inc.	$0.00	—	0.10	$11778	0.00%
NNLXNanoLogix, Inc.	$0.00	—	-0.01	$9569	0.00%
PXMDPaxMedica, Inc. Common Stock	$0.00	—	0.00	$88385	0.00%
QBIOQ BioMed Inc.	$0.00	—	0.00	$14509	0.00%

About Strategic Partners A/S

Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev. Historically, its primary focus was on biotechnology; however, it presently conducts no significant business operations.

Strategic Partners A/S is headquartered in DK.

Strategic Partners A/S (OZYMF) stock trades at $90.00 with a market capitalization of $3.72M. The stock is valued at a price-to-earnings (P/E) ratio of -36.17, price-to-book of 1.69, price-to-sales of 99.69. Over the past 52 weeks the stock has ranged between $0.09 and $90.00, and currently trades at its 52-week high.

On profitability, Strategic Partners A/S generates a return on equity (ROE) of -4.71%, return on capital employed of -13.30%, an operating margin of -791.59%, a net profit margin of -277.99%.

Official website: www.strategic-partners.dk

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides